Day two of the conference will be opened by Justine Rochon, Head of R&D Data and Quantitative Sciences, SVP at Takeda. Renowned for her visionary leadership and scientific expertise, Justine led the transformation of a global data science organization at a leading pharmaceutical company into an agile, data-driven powerhouse that redefined innovation culture and delivered outstanding results. A recognized catalyst for change, she has contributed to cross-industry collaborations, including a strategic alliance with major pharmaceutical partners and the CCAIM, a premier institute for AI-driven medicine in Cambridge, UK. Co-author of the Charter for Data Science in Pharmaceutical R&D and the Manifesto for AI-Driven Clinical Trials, she champions the transformative though realistic use of AI in drug development. Recently nominated for AI & Data Science Leader of the Year by the WomenTech Network, and listed in the 2025 Top 10 Trailblazing Women in Pharma by Reuters Events, Justine is widely recognised for her passion, leadership and expertise in AI-driven clinical trials. Following her keynote speech, she will join a panel discussion on the future of AI in our industry. More details coming soon!